Lineus Medical® Obtains Canadian Licence for SafeBreak® Vascular
PrAtlas/22707402

FAYETTEVILLE, Ark. - PrAtlas -- Health Canada has issued a licence on Lineus Medical's flag ship product, SafeBreak^® Vascular, for use on all vascular access lines including peripheral IV catheters, peripherally inserted central catheters, central venous catheters, midlines, IV ports, and interosseous vascular access devices on patients two weeks of age and up. This licence makes Lineus Medical the first company in the world to obtain authorization for the use of a break-away device on all vascular access lines and for both pediatric and adult patients in a country.

SafeBreak Vascular is the only breakaway device for IV lines proven to reduce IV complications.¹ When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. The separated device also causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. It's a win-win-win. Patients avoid additional needlesticks, nurses save time, and hospitals save money¹.

More on PrAtlas

• Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
• Cybersecurity is Protecting Your Personal Information and Your Portfolio
• L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
• Managing Summer Staffing Surges with Confidence: Why Name Badges Are a Must for Seasonal Success
• Visa Named Title Sponsor of Ascending Athletes' Business Owners Summits for NFL Entrepreneurs

Will Armstrong, COO of Lineus Medical stated, "This has been a year of growth for the company. This past May, SafeBreak received pediatric clearance for peripheral IVs from the US Food and Drug Administration, and now we are licenced on all lines for children and adults in Canada. We look forward to making SafeBreak available to every hospital and the over 38 million people living in Canada."

Vance Clement, CEO of Lineus Medical, stated, "Lineus Medical is the first company to obtain licence in a country on the full array of vascular lines across pediatric to adult aged patients. Not only are we expanding into every clinical setting including, Emergency Medical Services, veterinary care, and acute care hospitals systems, we are expanding internationally. Every patient, no matter where they live in the world, deserves a SafeBreak on their IV line."

ABOUT LINEUS MEDICAL

Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications¹. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found on the company website: www.lineusmed.com or you can follow the company on Facebook or LinkedIn.

More on PrAtlas

• The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
• $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
• SAVVY MINING raised $500 million and launched BTC.XRP.DOGE cloud mining, increasing investors' returns by 30%
• New National Nonprofit Launches to Capture Firsthand Accounts of Adoption Stories
• The Tide Project Opens at Biennale Architettura 2025 in Venice Amplifying Youth Voices

_{1. Data on File
MKG-0230 Rev 00}